Antimicrobial prophylaxis of travelers' diarrhea: a selected summary.
This paper summarizes the published controlled studies of the prophylaxis of travelers' diarrhea in which the following drugs have been used: neomycin, nonabsorbable sulfonamides, Streptotriad, doxycycline, erythromycin, and mecillinam. These studies have shown that antimicrobial prophylaxis can be highly effective in preventing episodes of travelers' diarrhea. The protection, however, lasts only as long as the drugs are being taken; there is no evidence that subclinical infections occur while the drug is being taken. None of the data suggest that antimicrobial prophylaxis increases the probability of infection with drug-resistant enteric pathogens. In these studies few subjects have experienced adverse drug reactions; however, the number of subjects has been too small to allow determination of accurate incidence data. Antimicrobial prophylaxis for travelers' diarrhea can be effectively and safely used on an individualized basis for persons traveling to areas of high risk.
D000560:Amdinocillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000517:prevention & control*; D004064:Digestive System / Q000382:microbiology; D004318:Doxycycline / Q000009:adverse effects / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000517:prevention & control; D006801:Humans; D010403:Penicillin Resistance; D014195:Travel
D000900:Anti-Bacterial Agents; D000930:Antidiarrheals; D004917:Erythromycin; D004318:Doxycycline; D000560:Amdinocillin